Citation 8073

RUNGELER,P: CASTRO,V: MORA,G: GOREN,N: VICHNEWSKI,W: PAHL,H: MERFORT,I: SCHMIDT,TJ:. (1999). INHIBITION OF TRANSCRIPTION FACTOR NF-KAPPA BY SESQUITERPENE LACTONES: A PROPOSED MOLECULAR MECHANISM OF ACTION.. 7(11)

Citation Details

Title	INHIBITION OF TRANSCRIPTION FACTOR NF-KAPPA BY SESQUITERPENE LACTONES: A PROPOSED MOLECULAR MECHANISM OF ACTION.
Authors	RUNGELER,P: CASTRO,V: MORA,G: GOREN,N: VICHNEWSKI,W: PAHL,H: MERFORT,I: SCHMIDT,TJ:
Year	1999
Volume	7
Issue	11

Summary

Year: 1999

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MEXICANIN I	ACTIVE
2	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	REYNOSIN,3-ALPHA-HYDROXY:	ACTIVE
3	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SANTAMARIN	ACTIVE
4	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CUMAMBRIN B	ACTIVE
5	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CUMAMBRIN A	ACTIVE
6	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AROMATICIN,2-3-DIHYDRO:	ACTIVE
7	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHAMISSONOLIDE	ACTIVE
8	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HELENALIN,11-ALPHA-13-DIHYDRO:	ACTIVE
9	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HELENALIN	ACTIVE
10	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PARTHENOLIDE	ACTIVE
11	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TIROTUNDIN	ACTIVE
12	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DIVERSIFOLIN	ACTIVE
13	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GOYAZENSOLIDE,ISO:	ACTIVE
14	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GOYAZENSOLIDE	ACTIVE
15	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CENTRATHERIN	ACTIVE
16	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EREMANTHOLIDE B,15-HYDROXY:	ACTIVE
17	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EREMANTHOLIDE A	INACTIVE
18	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TAMIRIN	ACTIVE

Show SPARQL Queries (1)